Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Niels Peter Nielsen, Elisabeth H. Wiig, Svante Bäck & Jan Gustafsson. (2017) Processing speed can monitor stimulant-medication effects in adults with attention deficit disorder with hyperactivity. Nordic Journal of Psychiatry 71:4, pages 296-303.
Read now
Read now
J. J. Sandra Kooij, Marieke Michielsen, Henk Kruithof & Denise Bijlenga. (2016) ADHD in old age: a review of the literature and proposal for assessment and treatment. Expert Review of Neurotherapeutics 16:12, pages 1371-1381.
Read now
Read now
Benchalak Maneeton, Narong Maneeton, Surinporn Likhitsathian, Sirijit Suttajit, Assawin Narkpongphun, Manit Srisurapanont & Pakapan Woottiluk. (2015) Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials. Drug Design, Development and Therapy 9, pages 1927-1936.
Read now
Read now
Articles from other publishers (17)
Nannet J. L. Buitelaar, Jocelyne A. Posthumus, Denise Bijlenga & Jan K. Buitelaar. (2019) The Impact of ADHD Treatment on Intimate Partner Violence in a Forensic Psychiatry Setting. Journal of Attention Disorders 25:7, pages 1021-1031.
Crossref
Crossref
Geon Ho Bahn, Young Sik Lee, Hanik K. Yoo, Eui-Jung Kim, Subin Park, Doug Hyun Han, Minha Hong, Bongseog Kim, Soyoung Irene Lee, Soo Young Bhang, Seung Yup Lee, Jin Pyo Hong & Yoo-Sook Joung. (2020) Development of the Korean Practice Parameter for Adult Attention-Deficit/Hyperactivity Disorder. Journal of the Korean Academy of Child and Adolescent Psychiatry 31:1, pages 5-25.
Crossref
Crossref
Brandon Gray, Cesar Hurtado, Jonell Hudson, Lois Coulter & Derrick Gray. (2020) Is bupropion monotherapy efficacious for ADHD in adults?. Evidence-Based Practice 23:10, pages 39-39.
Crossref
Crossref
J. J. Sandra Kooij, Denise Bijlenga & Marieke Michielsen. (2019) Assessment and Treatment of ADHD in People Over 60. The ADHD Report 27:4, pages 1-7,15-16.
Crossref
Crossref
J.J.S. Kooij, D. Bijlenga, L. Salerno, R. Jaeschke, I. Bitter, J. Balázs, J. Thome, G. Dom, S. Kasper, C. Nunes Filipe, S. Stes, P. Mohr, S. Leppämäki, M. Casas, J. Bobes, J.M. Mccarthy, V. Richarte, A. Kjems Philipsen, A. Pehlivanidis, A. Niemela, B. Styr, B. Semerci, B. Bolea-Alamanac, D. Edvinsson, D. Baeyens, D. Wynchank, E. Sobanski, A. Philipsen, F. McNicholas, H. Caci, I. Mihailescu, I. Manor, I. Dobrescu, T. Saito, J. Krause, J. Fayyad, J.A. Ramos-Quiroga, K. Foeken, F. Rad, M. Adamou, M. Ohlmeier, M. Fitzgerald, M. Gill, M. Lensing, N. Motavalli Mukaddes, P. Brudkiewicz, P. Gustafsson, P. Tani, P. Oswald, P.J. Carpentier, P. De Rossi, R. Delorme, S. Markovska Simoska, S. Pallanti, S. Young, S. Bejerot, T. Lehtonen, J. Kustow, U. Müller-Sedgwick, T. Hirvikoski, V. Pironti, Y. Ginsberg, Z. Félegyházy, M.P. Garcia-Portilla & P. Asherson. (2018) Updated European Consensus Statement on diagnosis and treatment of adult ADHD. European Psychiatry 56:1, pages 14-34.
Crossref
Crossref
Luana Salerno & J. J. Sandra Kooij. 2019. Psychopathology in Adolescents and Adults with Autism Spectrum Disorders. Psychopathology in Adolescents and Adults with Autism Spectrum Disorders
175
194
.
Kanit Tha Deang, Hatta Sidi, Hazli Zakaria, Raja Lope Adam, Srijit Das, Nurul Hazwani Hatta, Muhammad Hizri Hatta & Kok Wei Wee. (2018) The Novelty of Bupropion As a Dopaminergic Antidepressant for the Treatment of Adult Attention Deficit Hyperactive Disorder. Current Drug Targets 20:2, pages 210-219.
Crossref
Crossref
Wim Verbeeck, Geertruida E Bekkering, Wim Van den Noortgate & Cornelis Kramers. (2017) Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database of Systematic Reviews 2017:10.
Crossref
Crossref
Sara Loureiro‐Vieira, Vera Marisa Costa, Maria Lourdes Bastos, Félix Carvalho & João Paulo Capela. (2017) Methylphenidate effects in the young brain: friend or foe?. International Journal of Developmental Neuroscience 60:1, pages 34-47.
Crossref
Crossref
Hyo-Won Kim, Eunjoo Kim, Ji-Hoon Kim, Jangho Park, Geon Ho Bahn, Yeon Jung Lee, Kyungun Jhung & Dongwon Shin. (2017) The Revised Korean Practice Parameter for the Treatment of Attention-Deficit Hyperactivity Disorder (III) - Pharmacological Treatment -. Journal of the Korean Academy of Child and Adolescent Psychiatry 28:2, pages 70-83.
Crossref
Crossref
Laura G. Leahy. (2017) Off-Label Prescribing and Polypharmacy: Minimizing the Risks. Journal of Psychosocial Nursing and Mental Health Services 55:2, pages 17-22.
Crossref
Crossref
Franco De Crescenzo, Samuele Cortese, Nicoletta Adamo & Luigi Janiri. (2017) Pharmacological and non-pharmacological treatment of adults with ADHD: a meta-review. Evidence Based Mental Health 20:1, pages 4-11.
Crossref
Crossref
Maria Bianca Abrudan, Dana Maria Muntean, Ana Maria Gheldiu, Maria Adriana Neag & Laurian Vlase. (2017) The Pharmacokinetic Interaction Study between Carvedilol and Bupropion in Rats. Pharmacology 99:3-4, pages 139-143.
Crossref
Crossref
Alexander K.C. Leung & Kam Lun Hon. (2016) Attention-Deficit/Hyperactivity Disorder. Advances in Pediatrics 63:1, pages 255-280.
Crossref
Crossref
Paco Prada, Rosetta Nicastro, Julien Zimmermann, Roland Hasler, Jean-Michel Aubry & Nader Perroud. (2015) Addition of methylphenidate to intensive dialectical behaviour therapy for patients suffering from comorbid borderline personality disorder and ADHD: a naturalistic study. ADHD Attention Deficit and Hyperactivity Disorders 7:3, pages 199-209.
Crossref
Crossref
Stephen V. Faraone, Philip Asherson, Tobias Banaschewski, Joseph Biederman, Jan K. Buitelaar, Josep Antoni Ramos-Quiroga, Luis Augusto Rohde, Edmund J. S. Sonuga-Barke, Rosemary Tannock & Barbara Franke. (2015) Attention-deficit/hyperactivity disorder. Nature Reviews Disease Primers 1:1.
Crossref
Crossref
Sibylle C. Roll & Martina Hahn. (2015) Neue Behandlungsoptionen. DNP - Der Neurologe und Psychiater 16:2, pages 29-30.
Crossref
Crossref